New Definition of Steatotic Liver Disease Improves Prediction of Kidney Disease
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 20, 2024 -- Using a new classification of steatotic liver disease (SLD) based on the presence of metabolic dysfunction and alcohol consumption, metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (ALD) are significantly associated with the new onset of chronic kidney disease (CKD), according to a study published online Aug. 7 in Hepatology Research.
Kazuma Mori, M.D., from the Sapporo Medical University School of Medicine in Japan, and colleagues investigated the effects of various SLDs on the development of CKD. The analysis included 12,138 Japanese individuals with annual health examinations that included abdominal ultrasonography during a 10-year period.
The researchers found that during follow-up, 16.2 percent of participants (17.2 percent of men; 14.2 percent of women) had new onset of CKD. When adjusting for age, sex, estimated glomerular filtration rate, current smoking habit, diabetes mellitus, hypertension, and dyslipidemia, the risk for developing CKD was elevated in individuals with MASLD and those with ALD versus those with non-SLD; however, no association was seen for those with MASLD and increased alcohol intake. Compared with those with non-SLD, participants with SLD without metabolic dysfunction had a significantly lower risk for CKD. The addition of the novel classification of SLDs into traditional risk factors for the development of CKD significantly improved discriminatory capacity.
"In clinical practice, it is possible to identify patients at high risk for CKD among those with SLD by classifying hepatic steatosis according to the new classification of SLDs," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
Outcomes Similar for Neoadjuvant ICI-Based Therapy, Upfront Surgery for Liver Cancer
THURSDAY, Aug. 22, 2024 -- Patients treated with neoadjuvant immune checkpoint inhibitor (ICI)-based therapy for hepatocellular carcinoma (HCC) have higher-risk disease features...
Higher Protein Intake Tied to Lower Mortality in Chronic Kidney Disease
WEDNESDAY, Aug. 21, 2024 -- Higher intake of total, animal, and plant protein is associated with lower mortality in older adults with chronic kidney disease (CKD)...
Modest Gains in Life Expectancy Seen for Dialysis in Older Adults With eGFR
MONDAY, Aug. 19, 2024 -- For older adults, starting dialysis when the estimated glomerular filtration rate (eGFR) falls below 12 mL/min/1.73 m2 results in modest gains in life...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.